- Home
- KLRS vs SUNS Comparison
KLRS vs SUNS Comparison
Compare KLRS & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- SUNS
- Stock Information
- Founded
- KLRS 2019
- SUNS 2023
- Country
- KLRS United States
- SUNS United States
- Employees
- KLRS N/A
- SUNS N/A
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- SUNS Real Estate Investment Trusts
- Sector
- KLRS Health Care
- SUNS Real Estate
- Exchange
- KLRS Nasdaq
- SUNS Nasdaq
- Market Cap
- KLRS 129.0M
- SUNS 142.3M
- IPO Year
- KLRS N/A
- SUNS N/A
- Fundamental
- Price
- KLRS $2.69
- SUNS $9.87
- Analyst Decision
- KLRS Buy
- SUNS Strong Buy
- Analyst Count
- KLRS 1
- SUNS 3
- Target Price
- KLRS N/A
- SUNS $13.67
- AVG Volume (30 Days)
- KLRS 57.0K
- SUNS 52.9K
- Earning Date
- KLRS 08-15-2025
- SUNS 08-07-2025
- Dividend Yield
- KLRS N/A
- SUNS 12.16%
- EPS Growth
- KLRS N/A
- SUNS N/A
- EPS
- KLRS N/A
- SUNS 1.02
- Revenue
- KLRS N/A
- SUNS $13,066,680.00
- Revenue This Year
- KLRS N/A
- SUNS $185.50
- Revenue Next Year
- KLRS N/A
- SUNS $64.44
- P/E Ratio
- KLRS N/A
- SUNS $9.68
- Revenue Growth
- KLRS N/A
- SUNS 1342.10
- 52 Week Low
- KLRS $2.28
- SUNS $7.80
- 52 Week High
- KLRS $24.15
- SUNS $15.74
- Technical
- Relative Strength Index (RSI)
- KLRS N/A
- SUNS N/A
- Support Level
- KLRS N/A
- SUNS N/A
- Resistance Level
- KLRS N/A
- SUNS N/A
- Average True Range (ATR)
- KLRS 0.00
- SUNS 0.00
- MACD
- KLRS 0.00
- SUNS 0.00
- Stochastic Oscillator
- KLRS 0.00
- SUNS 0.00
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing therapeutics. Kalaris is developing TH103, a novel, clinical stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body native, highest affinity VEGF receptor 1.
About SUNS Sunrise Realty Trust Inc. Common Stock
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.